Skip to main content
Log in

Is liver transplantation indicated for cholangiocarcinoma?

  • Published:
Journal of Hepato-Biliary-Pancreatic Surgery

Abstract:

Liver transplantation (OLTx) has been investigated as a mode of therapy for malignancies. The efficacy of OLTx for the treatment of cholangiocarcinoma (CCA) has been somewhat controversial. We review the current literature on resective procedures for CCA and show that isolated intrahepatic CCA has a slightly better survival than extrahepatic disease. Results of OLTx for CCA are then reviewed, with specific attention to the experience at our center. Our results demonstrate that 1-year patient survival was 53%, and disease-free survival at 3 years was only 13%. Specific issues pertaining to the timing of OLTx in primary sclerosing cholangitis are then addressed. In summary, we believe that OLTx for known CCA results in a very poor patient survival. Those with incidental CCA found on explant histopathologic evaluation, without lymphatic involvement, may result in acceptable patient survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received for publication on June 6, 1997; accepted on July 7, 1997

About this article

Cite this article

Jeyarajah, D., Klintmalm, G. Is liver transplantation indicated for cholangiocarcinoma?. J Hep Bil Pancr Surg 5, 48–51 (1998). https://doi.org/10.1007/PL00009950

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00009950

Navigation